India’s Bharat Biotech has applied for “Emergency use authorization” (EUA) in the Philippines.
EUA was filed earlier this month in the country and is the first international regulatory filing for Bharat Biotech’s COVAXIN.
India is also expected to donate some doses and also open the door for exports in commercial terms, as is being done currently by Western and Chinese vaccine manufacturers.
